ITRMF · Iterum Therapeutics plc · Investor Relations
$0.03
+0.01 (+34.78%)
At close · Jul 21
Going-concern doubt
— flagged Nov 14, 2025
Substantial doubt about the company's ability to continue as a going concern.
“This condition raises substantial doubt about the Company's ability to continue as a going concern for one year from the date these condensed consolidated financial statements are issued.”View the 10-Q filed Nov 14, 2025
Market Cap
$446
Shares
44.66M
Press releases and events scraped from the company's investor relations website. Past events open our own call or event page when we host one; otherwise listings link to the original source.
Past events
| Date | Event | Type |
|---|---|---|
| 2026-02-18 | Extraordinary General Meeting of Shareholders | Shareholder meeting |
Source: https://ir.iterumtx.com/